Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 3 I, 1997, Pages 855-861

  Walther, Frans J ^a   Hernández Juviel, José ^b   Bruni, Roberta ^b   Waring, Alan J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; NONHUMAN; OXYGENATION; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030809770     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.3.9611053     Document Type: Article

References (36)

1. Hall, S. B., A. R. Venkitaraman, J. A. Whitsett, B. A. Holm, and R. H. Notter. 1992. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am. Rev. Respir. Dis. 145:24-30.
2. Nogee, L. M., G. Garnier, H. C. Dietz, L. Singer, A. M. Murphy, D. E. deMello, and H. R. Colten. 1994. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J. Clin. Invest. 93:1860-1863.
3. Haagsman, H. P., and M. van Eijk. 1995. Amounts of SP-B and SP-C in commercial surfactant preparations. Appl. Cardiopulm. Pathophysiol. 5(Suppl. 3):49-50.
4. Seeger, W., C. Grube, A. Günther, and R. Schmidt. 1993. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur. Respir. J. 6:971-977.
5. Soll, R. F., R. E. Hoekstra, J. J. Fangman, A. J. Corbet, J. M. Adams, L. S. James, K. Schulze, W. Oh, J. D. Roberts, Jr., J. P. Dorst, S. S. Kramer, A. J. Gold, E. M. Zola, J. D. Horbar, T. L. McAuliffe, J. F. Lucey, and the Ross Collaborative Surfactant Prevention Study Group. 1990. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome: Ross Collaborative Surfactant Prevention Study Group. Pediatrics 85:1092-1102.
6. Liechty, E. A., E. Donovan, D. Purohit, J. Gilhooly, B. Feldman, A. Noguchi, S. E. Denson, S. S. Sehgal, I. Gross, D. Stevens, M. Ikegami, R. D. Zachman, S. T. Carrier, J. H. Gunkel, and A. J. Gold. 1991. Reduction of neonatal mortality after multiple doses of bovine surfactant in low-birth-weight neonates with respiratory distress syndrome. Pediatrics 88:19-28.
7. Zola, E. M., A. M. Overbach, J. H. Gunkel, B. R. Mitchell, B. T. Nagle, N. G. DeMarco, G. A. Henwood, and A. J. Gold. 1993. Treatment investigational new drug experience with Survanta (beractant). Pediatrics 91:546-551.
8. Horbar, J. D., L. L. Wright, R. F. Soll, E. C. Wright, A. A. Fanaroff, S. B. Korones, S. Shankaran, W. Oh, B. D. Fletcher, C. R. Bauer, J. E. Tyson, J. A. Lemons, E. F. Donovan, B. J. Stoll, D. D. Stevensen, L.-A. Papile, J. Philips, and the National Institute of Child Health and Human Development Neonatal Research Network. 1993. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J. Pediatr. 123:757-766.
9. Vermont-Oxford Neonatal Network. 1996. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 97:1-6.
10. Mizuno, K., M. Ikegami, C.-M. Chen, T. Ueda, and A. H. Jobe. 1995. Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant. Pediatr. Res. 37:271-276.
11. Couser, R. J., T. B. Ferrara, J. Ebert, R. E. Hoekstra, and J. J. Fangman. 1990. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J. Pediatr. 116:119-124.
12. Bhat, R., K. Dziedzic, V. K. Bhutani, and D. Vidyasagar. 1990. Effect of single-dose surfactant on pulmonary function. Crit. Care Med. 18:590-595.
13. Waring, A., W. Taeusch, R. Bruni, J. Amirkhanian, B. Fan, R. Stevens, and J. Young. 1989. Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins. Peptide Res. 2:308-313.
14. Bruni, R., H. W. Taeusch, and A. J. Waring. 1991. Surfactant protein SP-B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain. Proc. Natl. Acad. Sci. U.S.A. 88:7451-7455.
15. Bruni, R., R. David-Cu, C. Navar, A. J. Waring, B. R. Fan, and H. W. Taeusch. 1994. Effects of acylation on structural and functional properties of a synthetic replica of surfactant protein C. In E. V. Cosmi and G. C. De Renzo, editors. Current Progress in Perinatal Medicine. Parthenon, New York. 869-875.
16. Holm, B. A., and A. J. Waring. 1993. Designer surfactants: the next generation in surfactant replacement. Clin. Perinatol. 20:813-829.
17. Fields, C. G., D. H. Loyd, R. L. McDonald, K. M. Ottenson, and R. L. Nobel. 1991. HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res. 4:95-101.
18. Lipp, M. M., K. Y. C. Lee, J. A. Zasadzinski, and A. J. Waring. 1996. Phase and morphology changes in lipid monolayers induced by SP-B protein and its amino-terminal peptide. Science 273:1196-1199.
19. Ellman, G. L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:70-77.
20. Amirkhanian, J. D., R. Bruni, A. J. Waring, C. Navar, and H. W. Taeusch. 1993. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum. Biochim. Biophys. Acta 1168: 315-320.
21. Bruch, M. D., C. J. McKnight, and L. M. Gierasch. 1989. Helix formation and stability in a signal sequence. Biochemistry 28:8554-8561.
22. Johansson, J., T. Szyperski, T. Curstedt, and K. Wuthrich. 1994. The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich α-helix. Biochemistry 33:6015-6023.
23. Baatz, J. E., K. L. Smyth, J. A. Whitsett, C. Baxter, and D. R. Absolom. 1992. Structure and functions of a dimeric form of surfactant protein C, a Fourier transform infrared and surfactometry study. Chem. Phys. Lipids 63:91-104.
24. Lapidot, Y., S. Rappoport, and Y. Wolman. 1967. Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids. J. Lipid Res. 8:142-145.
25. Revak, S. D., T. A. Merritt, M. Hallman, G. Heldt, R. J. La Polla, K. Hoey, R. A. Houghten, and C. G. Cochrane. 1991. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr. Res. 29:460-465.
26. Cochrane, C. G., and S. D. Revak. 1991. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254:566-568.
27. 4-surfactant in preterm infants with respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:404-410.
28. Revak, S. D., T. A. Merritt, C. G. Cochrane, G. P. Heldt, M. S. Alberts, D. W. Anderson, and A. Kheiter. 1996. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr. Res. 39:715-724.
29. Keough, K. M. W., E. Farrell, M. Cox, G. Harrell, and H. W. Taeusch. 1985. Physical, chemical, and physiological characteristics of isolates of pulmonary surfactant from adult rabbits. Can. J. Physiol. Pharmacol. 63:1043-1051.
30. Longo, M. L., A. M. Bisagno, J. A. N. Zasadzinski, R. Bruni, and A. J. Waring. 1993. The function of lung surfactant protein SP-B. Science 261:453-456.
31. Armsby, D. H., G. Bellon, K. Carlisle, D. Rector, R. Baldwin, W. Long, D. K. Stevenson, and R. L. Ariagno. 1992. Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant. Pediatr. Pulmonol. 14:206-213.
32. Bhutani, V. K., S. Abbasi, W. A. Long, and J. S. Gerdes. 1992. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. J. Pediatr. 120:S18-S24.
33. Kobayashi, T., H. Kataoka, T. Ueda, S. Murakami, Y. Takada, and M. Kukubo. 1984. Effects of surfactant supplement and end-expiratory pressure in lung-lavaged rabbits. J. Appl. Physiol. 57:995-1001.
34. Rider, E. D., A. H. Jobe, M. Ikegami, and B. Sun. 1992. Different ventilation strategies alter surfactant responses in preterm rabbits. J. Appl. Physiol. 73:2089-2096.
35. Merritt, T. A., A. Kheiter, and C. G. Cochrane. 1995. Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome. Pediatr. Res. 38:211-217.
36. Gustafsson, M., G. Vandenbussche, T. Curstedt, J. M. Ruysschaert, and J. Johansson. 1996. The 21-residue surfactant peptide (LysLeu4)4Lys (KL4) is a transmembrane alpha-helix with a mixed nonpolar/polar surface. FEBS Lett. 384:185-188.